Subham Preetam | Nano-robots | Editorial Board Member

Mr. Subham Preetam | Nano-robots | Editorial Board Member

Monash University | India

Mr. Subham Preetam is a distinguished Transfusion Medicine specialist recognized for impactful clinical research, academic contributions, and leadership in advancing evidence-based transfusion practices. With an h-index of 17, a research portfolio of 40 documents, and 1,102 citations across 904 citing documents, Mr. Preetam has established a strong scientific footprint in areas such as apheresis, patient blood management, therapeutic plasma exchange, leukocytapheresis, immunohematology, and transfusion safety. His academic journey includes an MBBS, an MD in Transfusion Medicine, and advanced clinical training through a PDCC in Apheresis and Blood Component Therapy. Professionally, he has served as Senior Resident and faculty in leading national medical institutes, contributing significantly to service development, SOP formulation, staff training, and quality systems in transfusion services. His research interests span clinical apheresis, hemovigilance, transfusion reactions, donor health, PBM strategies, and improving transfusion outcomes. Mr. Preetam has earned recognition through prestigious national awards and has contributed to international working groups, editorial activities, invited sessions, and collaborative projects that strengthen global transfusion medicine practices. His continued dedication reflects a commitment to improving clinical standards, fostering academic excellence, and promoting innovation in transfusion medicine for enhanced patient care.

Profiles: Scopus | Orcid

Featured Publications

Preetam, S., Lata, S., Aditi, Bora, J., Thapliyal, S., Mehta, S., Ramniwas, S., Deshwal, R., Rustagi, S., Talukdar, N., et al. (2025). Exosome-driven biohybrid nanorobots: Bridging nature and nanotechnology in biomedical innovation. RSC Advances. https://doi.org/10.1039/D5RA05296C

Dhasmana, A., Santhanam, A., Dhasmana, K., Malik, S., & Preetam, S. (2025). Innovative smart biosensors for cancer theranostics: A new frontier in detection, diagnosis, and beyond. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.100911

Dhasmana, A., Dobhal, P., Sati, A., Santhanam, A., Preetam, S., Malik, S., Joshi, N., Rustagi, S., & Deshwal, R. K. (2025). Synthesis of fungal polysaccharide-based nanoemulsions for cancer treatment. RSC Advances. https://doi.org/10.1039/D5RA01349F

Bhattacharya, T., Das, T., Preetam, S., & Chopra, H. (2025). Cutting-edge developments in agro-waste derived carbon nanomaterials and their multifaceted applications in agriculture: Enhancing crop imaging, nutrient efficiency, and plant health. Zeitschrift für Naturforschung C. https://doi.org/10.1515/znc-2024-0205

Preetam, S., Mishra, R., Thapliyal, S., Rustagi, S., Deshwal, R. K., Ramniwas, S., Dhasmana, A., Rajab, B. S., Alghamdi, S., & Malik, S. (2025). Bioactive coatings for cardiovascular stents: Modulating immune response for enhanced performance. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01166

Rajagopal M R | Pallium India | Best Researcher Award

Dr. Rajagopal M R | Pallium India | Best Researcher Award

Pallium | India

Dr. M. R. Rajagopal is a distinguished Indian physician and global leader in palliative care. He is the Founder and Chairman Emeritus of Pallium India and Adjunct Professor of Global Oncology at Queen’s University, Canada. A pioneer of pain and palliative medicine in India, he co-founded the Pain and Palliative Care Society at Calicut Medical College in 1993, which became a WHO-recognized model project. His advocacy and collaboration with the Government of India and WHO have led to significant policy reforms improving access to opioids and pain relief nationwide. Dr. Rajagopal has served as Commissioner for two Lancet Commissions—on Global Access to Palliative Care and Pain Relief, and on the Value of Death. His scientific contributions span numerous journal publications, textbook chapters, and authorship of Walk with the Weary. He serves on editorial boards of multiple international journals. Recipient of numerous national and international honors—including the Padma Shri (2018), John Mendelsohn Award (2018), and D.Sc. (2024)—Dr. Rajagopal’s work has redefined compassionate end-of-life care in India and influenced global health policies. Through Pallium India and his continued leadership, he remains instrumental in training, advocacy, and advancing palliative care accessibility worldwide.

Profiles: Google Scholar | Scopus

Featured Publications

Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Kwete, X. J., Rajagopal, M. R., et al. (2018). Alleviating the access abyss in palliative care and pain relief—An imperative of universal health coverage: The Lancet Commission report. The Lancet, 391(10128), 1391–1454. https://doi.org/10.1016/S0140-6736(17)32513-8

Radbruch, L., De Lima, L., Knaul, F., Wenk, R., Ali, Z., Bhatnaghar, S., Rajagopal, M. R., et al. (2020). Redefining palliative care—A new consensus-based definition. Journal of Pain and Symptom Management, 60(4), 754–764. https://doi.org/10.1016/j.jpainsymman.2020.04.027

Sallnow, L., Smith, R., Ahmedzai, S. H., Bhadelia, A., Chamberlain, C., Cong, Y., Rajagopal, M. R., et al. (2022). Report of the Lancet Commission on the Value of Death: Bringing death back into life. The Lancet, 399(10327), 837–884. https://doi.org/10.1016/S0140-6736(21)02314-X

Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Rajagopal, M. R., et al. (2018). Alleviating the access abyss in palliative care and pain relief—An imperative of universal health coverage. The Lancet, 391(10128), 1391–1454.

Rajagopal, M. R., Joranson, D. E., & Gilson, A. M. (2001). Medical use, misuse, and diversion of opioids in India. The Lancet, 358(9276), 139–143. https://doi.org/10.1016/S0140-6736(01)05330-1